Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 07:49 PM EDT
Outlook Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 7.56M | 5.7M | 14.93M | 32.02M | 47.23M | 10.36M | 23.39M | 33.71M | 43.63M | 52.34M | 17.4M | 26.02M | 58.42M | 70.15M | 14.48M | 19.69M | 37.17M | 5.57M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 623.49K | 659.89K | 693.19K | 708.39K | 765.88K | 796.48K | 793.93K | 802.28K | 809.47K | 826.43K | 804.93K | 812.16K | 823.96K | 830K | 853.66K | 464.65K | 900K | n/a |
Other Long-Term Assets | 393.83K | 415.97K | 439.28K | 479.23K | 473.24K | 484.32K | 501.3K | 589.37K | 113.85K | 126.44K | 132.01K | 140.36K | 141.86K | 156.7K | 174.59K | 194.35K | 6.8M | 1.07M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 3.6M | 3.11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.65M | 6.86M | 12.49M | 13.59M | 10.56M | 10.03M | 7.59M | 9.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 17.81M | 15.67M | 27.42M | 45.62M | 57.79M | 20.39M | 30.98M | 43.02M | 53.05M | 61.68M | 27.52M | 37.51M | 66.55M | 77.47M | 21.51M | 31.9M | 37.17M | 11.03M |
Property-Plant & Equipment | 250.7K | 262.82K | 274.64K | 286.46K | 3.74K | 14.96K | 26.17K | 37.39K | 48.58K | 59.58K | 70.36K | 121.83K | 173.1K | 224.19K | 275.05K | 325.73K | 245.44K | 413.12K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.27M | 1.34M | 1.41M | 1.47M | 1.24M | 1.3M | 1.32M | 1.43M | 971.9K | 1.01M | 1.01M | 1.07M | 1.14M | 1.21M | 1.3M | 984.74K | 7.94M | 1.49M |
Total Assets | 19.08M | 17.01M | 28.82M | 47.09M | 59.03M | 21.68M | 32.3M | 44.45M | 54.02M | 62.69M | 28.53M | 38.59M | 67.69M | 78.68M | 22.81M | 32.88M | 45.11M | 12.52M |
Account Payables | 7.77M | 12.19M | 7.97M | 5.55M | 4.36M | 3.48M | 6.57M | 5.06M | 3.62M | 4.17M | 3.49M | 2.48M | 4.16M | 2.55M | 2.2M | 2.67M | 6.33M | 3.33M |
Deferred Revenue | n/a | n/a | n/a | -890.56K | 1.86M | n/a | n/a | n/a | n/a | n/a | n/a | 1.86M | 1.86M | -12.65M | 1.02M | 1.86M | 1.86M | -594.17K |
Short-Term Debt | 12M | 30.74M | 29.44M | 32.43M | 44.74M | 36.54M | 35.55M | 34.73M | 31.82M | n/a | 10.92M | 10.46M | 22.78M | 12.72M | 904.2K | 11.55M | 11.18M | 425.52K |
Other Current Liabilities | 1.31M | n/a | 2.22M | 890.56K | 118.8K | n/a | n/a | 8.18M | 6.41M | 8.38M | 3.31M | 4.11M | 3.63M | 3.58M | 2.83M | 4.9M | 5.5M | 7.48M |
Total Current Liabilities | 24.82M | 48.24M | 42.55M | 42.55M | 54.08M | 45.97M | 46.73M | 49.93M | 43.53M | 15.08M | 19.73M | 18.43M | 31.41M | 19.95M | 6.75M | 19.64M | 23.9M | 12.12M |
Long-Term Debt | 21.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31.82M | n/a | n/a | n/a | 9.6M | 10.89M | n/a | 129.17K | 10.66M |
Other Long-Term Liabilities | 5.45M | 18.83M | 59.1M | 87.95M | 139.18M | 59.56K | 6.22K | 20.01K | 8.26K | 26.88K | 57.14K | 68.32K | 298.03K | 273.02K | 522.92K | 434.25K | 405.07K | 176.09K |
Total Long-Term Liabilities | 26.72M | 19.06M | 59.35M | 88.21M | 139.18M | 59.56K | 6.22K | 20K | 8K | 31.85M | 61.41K | 75.67K | 312.29K | 9.91M | 11.45M | 494.15K | 563K | 10.87M |
Total Liabilities | 51.54M | 67.3M | 101.9M | 130.77M | 193.26M | 46.03M | 46.74M | 49.95M | 43.54M | 46.93M | 19.79M | 18.51M | 31.72M | 29.85M | 18.2M | 20.13M | 24.46M | 22.99M |
Total Debt | 33.32M | 31.03M | 29.74M | 32.72M | 44.74M | 36.55M | 35.56M | 34.74M | 31.84M | 31.85M | 10.96M | 10.52M | 22.86M | 22.42M | 11.9M | 11.68M | 11.37M | 11.29M |
Common Stock | 329.07K | 249.06K | 239.06K | 234.06K | 220.13K | 2.6M | 2.6M | 2.59M | 2.57M | 2.57M | 2.27M | 2.26M | 2.26M | 2.24M | 1.76M | 1.75M | 1.74M | 1.27M |
Retained Earnings | -572.26M | -525.91M | -543.28M | -548.98M | -593.39M | -479.1M | -467.92M | -454.93M | -434.25M | -427.6M | -408.94M | -394.59M | -377.05M | -357.35M | -342.88M | -329.48M | -317.28M | -304.18M |
Comprehensive Income | n/a | n/a | n/a | n/a | -59,028.7B | -21,685B | -32,300.6B | -44,447.2B | 444.74M | 443.36M | 417.67M | 414.67M | 413.01M | -78,678.1B | n/a | -32,882.1B | 337.93M | -781.01K |
Shareholders Equity | -32.46M | -50.29M | -73.08M | -83.67M | -134.24M | -24.34M | -14.44M | -5.5M | 10.49M | 15.76M | 8.74M | 20.08M | 35.96M | 48.82M | 4.61M | 12.75M | 20.65M | -10.47M |
Total Investments | 623.49K | 659.89K | 693.19K | 708.39K | 765.88K | 796.48K | 793.93K | 802.28K | 809.47K | 826.43K | 804.93K | 812.16K | 823.96K | 830K | 853.66K | 464.65K | 900K | n/a |